Stocks TelegraphStocks Telegraph
Stock Ideas

CHRO Company Profile and Key Details

AMEX : CHRO

Chromocell Therapeutics Corporation

$1.90
0.94+97.92%
At Close 4:00 PM

CHRO Stock Price Chart

Stock Price Today

Chromocell Therapeutics Corporation (CHRO) stock surged +97.92%, trading at $1.90 on AMEX, up from the previous close of $0.96. The stock opened at $1.09, fluctuating between $1.00 and $2.44 in the recent session.

Stock Snapshot

0.96
Prev. Close
1.09
Open
11.45M
Market Cap
6.03M
Number of Shares
1
Day Low
2.44
Day High
-1.06
P/E Ratio
29.89%
Free Float in %
-1.79
EPS (TTM)
N/A
Book Value
N/A
Cash Flow per Share
14.11M
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Jan 17, 20251.092.451.001.9014M
Jan 16, 20250.991.450.810.96618.04K
Jan 15, 20250.931.040.910.9724.21K
Jan 14, 20250.901.050.870.9412.77K
Jan 13, 20250.861.060.850.9077.75K
Jan 10, 20251.011.070.810.9093.13K
Jan 08, 20250.931.100.861.01222.4K
Jan 07, 20250.810.920.800.9299.82K
Jan 06, 20250.840.840.760.7812.8K
Jan 03, 20250.740.890.720.80185.34K
Jan 02, 20250.670.730.630.72102.94K
Dec 31, 20240.650.660.620.64129.13K
Dec 30, 20240.630.650.600.63121.13K
Dec 27, 20240.680.680.630.6330.18K
Dec 26, 20240.630.670.610.6628.35K
Dec 24, 20240.650.650.590.6323.7K
Dec 23, 20240.650.650.600.6432.64K
Dec 20, 20240.650.650.560.64166.8K
Dec 19, 20240.590.650.590.65157.66K
Dec 18, 20240.680.690.560.59642.11K

Contact Details

Freehold, NJ 07728

United States

Website: https://chromocell.comContact: 732 514 2636

About Company

Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.

Company Information

Employees4
Beta0
Sales or RevenueN/A
5Y Sales Change%-1%
Fiscal Year EndsN/A
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Chromocell Therapeutics Corporation (CHRO) stock price?

Chromocell Therapeutics Corporation (AMEX: CHRO) stock price is $1.90 in the last trading session. During the trading session, CHRO stock reached the peak price of $2.44 while $1.00 was the lowest point it dropped to. The percentage change in CHRO stock occurred in the recent session was 97.92% while the dollar amount for the price change in CHRO stock was $0.94.

CHRO's industry and sector of operation?

The AMEX listed CHRO is part of Biotechnology industry that operates in the broader Healthcare sector. Chromocell Therapeutics Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CHRO?

No Data

How CHRO did perform over past 52-week?

CHRO's closing price is 322.22% higher than its 52-week low of $0.45 where as its distance from 52-week high of $6.00 is -68.33%.

How many employees does CHRO have?

Number of CHRO employees currently stands at 4.

Link for CHRO official website?

Official Website of CHRO is: https://chromocell.com

How do I contact CHRO?

CHRO could be contacted at phone 732 514 2636 and can also be accessed through its website. CHRO operates from 4400 Route 9 South, Freehold, NJ 07728, United States.

How many shares of CHRO are traded daily?

CHRO stock volume for the day was 14.11M shares. The average number of CHRO shares traded daily for last 3 months was 122.34K.

What is the market cap of CHRO currently?

The market value of CHRO currently stands at $11.45M with its latest stock price at $1.90 and 6.03M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph